跳至主要内容
临床试验/NCT01885299
NCT01885299招募中不适用

Multi-Institution Registry of SRS/SBRT Procedures

The Radiosurgery Society13 个研究点 分布在 1 个国家目标入组 50,000 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50,000
试验地点
13
主要终点
Overall survival

研究概览

简要总结

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

详细描述

The Registry is designed to help SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) users to understand utilization of and key treatment outcomes for these treatment approaches. Some of the objectives include:

Allow participants to record information about usage of SRS/SBRT in everyday practice, including patient characteristics and disease information, treatment plans and outcomes Provide participants with ready access to data for publication of their own experience and as a tool for establishing collaborations with other participating sites Facilitate quality improvement efforts for individual treatment providers Understand the effectiveness of different treatment plans for different types of lesions, diseases and treatments

The Registry tracks select outcomes for each condition treated by SRS/SBRT (for example, PSA for prostate cancer); the Registry also provides individual participants the ability to add additional outcomes for each and any condition of specific interest to their institutions.

The Registry is hosted by Vision Tree, Inc who is an independent vendor of electronic registries; they are responsible for HIPAA compliance, including all security mechanisms.

Patients will be enrolled prospectively. Some retrospective patient data is likely to be included in order to capture both short and longer term outcomes data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
  • Willingness to sign an Informed Consent Document or verbally agree to participation

排除标准

  • There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

结局指标

主要结局

Overall survival

时间窗: Up to 5 years

Survival from time of treatment to death

次要结局

  • Local and distant recurrence(One to Five years)

研究者

发起方
The Radiosurgery Society
申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验